Altiratinib

Item number	Size	Delivery time	Price
TGM-T2054-5mg	5 mg	7 - 10 business days*	48.00€
TGM-T2054-1mL	1 ml	7 - 10 business days*	55.00€
TGM-T2054-10mg	10 mg	7 - 10 business days*	79.00€
TGM-T2054-25mg	25 mg	7 - 10 business days*	139.00€
TGM-T2054-50mg	50 mg	7 - 10 business days*	223.00€
TGM-T2054-100mg	100 mg	7 - 10 business days*	336.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor, effectively... more

Close menu

Product information "Altiratinib"

Description: Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor, effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro. Target: c-Met/HGFR, FLT, Tie-2, Trk receptor, VEGFR. Smiles: Fc1ccc(NC(=O)C2(CC2)C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)C4CC4)c3)cc2F)cc1. References: Kwon Y, et al. Oncogene. 2015 Jan 8,34(2):144-53.

Keywords:	DCC-2701
Supplier:	TargetMol
Supplier-Nr:	T2054

Properties

Application:	Targets proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1] (MET, HGFR)
MW:	510.46 D
Formula:	C26H21F3N4O4
Format:	32160405

Database Information

CAS :	1345847-93-9\| Matching products
KEGG ID :	K05098 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Altiratinib"

Write a review